Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donna Fitzgerald

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Emergency Nursing|March 10, 2012
Response to January JEN editor's messageDonna Fitzgerald
The Science of the Total Environment|March 10, 2023
Population decline in a Pleistocene refugium: Stepwise, drought-related dieback of a South Australian eucalyptGunnar Keppel, Udo Sarnow, Ed Biffin, et al.
Journal for Immunotherapy of Cancer|August 30, 2024
Eganelisib combined with immune checkpoint inhibitor therapy and chemotherapy in frontline metastatic triple-negative breast cancer triggers macrophage reprogramming, immune activation and extracellular matrix reorganization in the tumor microenvironmentBrenda C O'Connell, Charley Hubbard, Nora Zizlsperger, et al.
Blood|October 30, 2010
Vaccination with dendritic cell/tumor fusion cells results in cellular and humoral antitumor immune responses in patients with multiple myelomaJacalyn Rosenblatt, Baldev Vasir, Lynne Uhl, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Emergency Nursing|March 10, 2012
Response to January JEN editor's messageDonna Fitzgerald
The Science of the Total Environment|March 10, 2023
Population decline in a Pleistocene refugium: Stepwise, drought-related dieback of a South Australian eucalyptGunnar Keppel, Udo Sarnow, Ed Biffin, et al.
Journal for Immunotherapy of Cancer|August 30, 2024
Eganelisib combined with immune checkpoint inhibitor therapy and chemotherapy in frontline metastatic triple-negative breast cancer triggers macrophage reprogramming, immune activation and extracellular matrix reorganization in the tumor microenvironmentBrenda C O'Connell, Charley Hubbard, Nora Zizlsperger, et al.
Blood|October 30, 2010
Vaccination with dendritic cell/tumor fusion cells results in cellular and humoral antitumor immune responses in patients with multiple myelomaJacalyn Rosenblatt, Baldev Vasir, Lynne Uhl, et al.
Pageof 1